Ravulizumab-Cwvz
PubChem Reference Collection SID
PubChem CID
Not available and might not be a discrete structure.
Synonyms
Ravulizumab-Cwvz
See also: Ravulizumab (subclass of).
Ravulizumab-Cwvz
Ravulizumab (subclass of)
Drug
Active Ingredient
Form;Route
Company
Date
Drug
Active Ingredient
RAVULIZUMAB-CWVZ
Form;Route
INJECTABLE;INJECTION
Company
ALEXION PHARM
Date
06/28/2024
Application Number
Proper Name
ravulizumab-cwvz
Status
Rx
Dosage Form
Injection; Injection
Route of Administration
Subcutaneous; Intravenous
Product Presentation
Single-Dose Cartridge; Single-Dose Vial
BLA Type
351(a)
Licensure
Licensed No. 1743
Date
December 21, 2018; June 22, 2022; October 09, 2020
Company
Alexion Pharmaceuticals, Inc.
- PubChem
- Drugs@FDALICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingRAVULIZUMAB-CWVZhttps://www.accessdata.fda.gov/scripts/cder/daf/
- FDA Medication GuidesLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingULTOMIRIShttps://dps.fda.gov/medguide
- FDA Purple Bookravulizumab-cwvzhttps://purplebooksearch.fda.gov/productdetails?query=761108
CONTENTS